Menu
Recruiting NCT04681339

Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia

Observational Community Acquired Pneumonia in Children Antibiotic Stewardship

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Antibiotic treatment, No antibiotic treatment.
Who it may be relevant to
Registry conditions: Community Acquired Pneumonia in Children, Antibiotic Stewardship. Basic parameters: 3 months — 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia: a Prospective, Observational Study

Overview

A study to observe how often antibiotics are prescribed in children hospitalized for pneumonia and how doctors decide if a child needs antibiotics or not. Parent satisfaction will also be recorded.

Detailed description

An observational study to document the antibiotic treatment rate of children hospitalized for community acquired pneumonia at a pediatric department with longstanding practice of restrictive antibiotic prescribing. Patients will be enrolled consecutively and treated according to in-house standard operating procedure. Antibiotic treatment rate, severity of disease and medical complication rate in antibiotic and non-antibiotic managed children, frequency of predefined factors in physician decision making on antibiotic use, and parental satisfaction will be recorded. Parents will be contacted at least 4 weeks after discharge to inquire about recurrence or readmission.

Interventions

  • Other Antibiotic treatment
    Antibiotic treatment
  • Other No antibiotic treatment
    No antibiotic treatment

Primary outcome measures

  • Antibiotic treatment rates in hospitalized children with non-severe community-acquired pneumonia and fever [Time frame: During hospitalization, an average of 7 days]
Secondary outcome measures (9)
  • Number of medical complications [Time frame: During hospitalization, an average of 7 days]
  • Factors in physician decision making on antibiotic prescription [Time frame: During hospitalization, an average of 7 days]
  • Parental satisfaction [Time frame: At discharge, assessing the entire duration of the hospital stay, an average of 7 days]
  • Hospitalization duration [Time frame: At discharge, assessing the entire duration of the hospital stay, an average of 7 days]
  • Number of children with relevant comorbidity [Time frame: During hospitalization, an average of 7 days]
  • Days of supplemental oxygen use [Time frame: During hospitalization, an average of 7 days]
  • Use of antipyretic medications [Time frame: During hospitalization, an average of 7 days]
  • Number of complementary medicine medications used per child [Time frame: During hospitalization, an average of 7 days]
  • Number of readmissions for pneumonia or new pneumonia recurrences within 4 weeks of hospital discharge [Time frame: 4 weeks after end of hospitalization]

Eligibility criteria

Inclusion criteria

  • Hospital admission at the pediatric department of the Filderklinik or at the pediatric department of the Herdecke Community Hospital
  • Admission diagnosis pneumonia or pneumonia diagnosis within 48 hours of admission
  • Written informed consent by care giver
  • All inclusion criteria have to be fulfilled

Exclusion criteria

  • Insufficient knowledge of German to understand the written patient information and questionnaire

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Germany · 2 centers
  • Die Filderklinik — Filderstadt
  • Herdecke Community Hospital — Herdecke

Identifiers

NCT: NCT04681339 · PKA-03

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗